Adherence to HIV combination therapy

Social Science and Medicine

Volumn 50, Issue 11, 2000, Pages 1599-1605

  Chesney, Margaret A ^a   Morin, Michel ^b,c   Sherr, Lorraine ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Aix Marseille   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Adherence; Combination therapy; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; ZIDOVUDINE;

BEHAVIORAL RESPONSE; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SOCIAL ASPECT;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV; HIV INFECTIONS; HUMANS; LIFE STYLE; PATIENT COMPLIANCE;

EID: 0034010539     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(99)00468-2     Document Type: Conference Paper

References (45)

1. Abelhauser A. Observance, compliance ou adhésion? enjeux sociaux et mécanismes psychiques. 2nd European Conference on the methods and results of Social and Behavioural Sciences: AIDS in Europe. New challenges for social and behavioural sciences. 1998.
2. Baker, R., 1996. Summary sheets on HIV protease inhibitor drugs: Indinavir, ritonavir, saquinavir, BETA.
3. Brigido L.F.M., Veiga A.P., d'Ambrosio A.C., Bueno A., Casseb J., Galbitti F.F. Low adherence in antiRetroviral users at Sao Paulo, Brazil. Abstract 32370, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
4. Broers B., Morabia A., Hirshel B. A cohort study of drug users' compliance with zidovudine treatment. Archs Intern Med. 154:1994;1121-1127.
5. Brooks G.M., Richards J.M., Kohler C.L., Soong S.J. Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales. Medical Care. 32:1996;298-307.
6. Carpenter C.C., Fischl M., Hammer S.M., Hirsch M., Jacobsen D., Katzenstein D., et al. Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society - USA panel. JAMA. 277:1997;1962-1969.
7. Chambon J.F. Les implications des essais ACTG 175 et Delta: Paradoxe. Le Journal du Sida. 78:1995;4-8.
8. Chesney M., Ickovics J. Adherence to combination therapy in AIDS clinical trials. Presented at the Annual Meeting of the AIDS Clinical Trials Group, July, Washington, DC. 1997.
9. Deeks S.G., Smith M., Holodniy M., Kahn J.O. HIV-1 protease inhibitors. A review for clinicians. JAMA. 277:(2):1997;145-153.
10. Dormont, J., 1997 (sous la direction de). Stratégies d'utilisation des antirétroviraux dans l'infection par le VIH. Recommendation des groupes d'experts et virologues Paris, Direction des Hopitaux.
11. Dormont, J., 1998 (sous la direction de). Stratégies d'utilisation des antirétroviraux dans l'infection par le VIH. Recommendation des groupes d'experts et virologues. Ministère de l'Emploi et de la Solidarité, Secrétariat d'Etat à la Santé.
12. Dunbar-Jacob J., Burke L.E., Puczynski S. Clinical assessment and management of adherence to medical regimens. Nicassio P.M., Smith T.W. Managing Chronic Illness. 1995;American Psychological Association, Washington, DC.
13. Eldred L.J., Wu A., Chaisson R., Moore R.D. Adherence to antiretroviral therapy in HIV disease. Fourth Conference on Retroviruses and Opportunistic Infections, January 1997, Washington, DC. 1997.
14. Eraker S.A., Kirscht J.P., Becker M.H. Understanding and improving patient compliance. Annals of Internal Medicine. 100:(2):1984;258-268.
15. Giami A. La compliance des patients en questions. Psychologues et Psychologies. 139:1996;17-19.
16. Gidron Y. Adherence in hypertension and Coronary Heart Disease. Myers L.B., Midence K. Adherence to treatment in medical conditions. 1998;Harwood Academic, The Netherlands.
17. Gifford A.L., Shively M.J., Bormann J.E., Timberlake D., Bozzette S.A. Self-reported adherence to antiretroviral medication (ARV) regimens in a community-based sample of HIV-infected adults. Abstract 32338, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
18. Hand C. Adherence and asthma. Myers L.B., Midence K. Adherence to Treatment in Medical Conditions. 1998;Harwood Academic, The Netherlands.
19. Haynes R., Taylor D., Sackett D. Compliance in Health Care. 1979;Johns Hopkins University Press, Baltimore.
20. Hecht F.M., Colfax G., Swanson M., Chesney M. Adherence and effectiveness of protease inhibitors in clinical practice. Fifth Conference on Retroviruses and Opportunistic Infections; 2-6 February, Chicago, Illinois. 1998.
21. Hecht F., Kahn J.O., Dillon B., Chesney M., Grant R.M. Transmission of protease inhibitor resistant HIV-1 to a recently infected antiretroviral-naïve man: The UCSF-options primary HIV project. Abstract 32288, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
22. Hirschhorn L., Quinones J., Goldin S., Metras L. Highly active antiretroviral therapy (HAART) in the "Real World": Experiences in an inner-city community health center (CHC). Abstract 32334, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
23. Kissinger P., Cohen O., Brandon W., Rice J., Morse A., Clark R. Compliance with public sector HIV medical care. J. Natl Med. Assoc. 87:1995;19-34.
24. Klosinski L.E., Brooks R.N.A. Predictors of nonadherence to HIV combination therapies. Abstract 32375, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
25. Knobel H., Serrano C., Hernandez P., Pavesi M., Diez A. Acceptance of, compliance with and tolerance to antiretroviral treatment in patients with human immunodeficiency virus infection (article in Spanish). An. Med. Intern. 14:(9):1997;445-449.
26. Knobel H., Carmona A., Grau S., Sabalis P., Gimeno J.L., Lopez Colomes J.L. Strategies to optimise adherence to highly active antiretroviral treatment. Abstract 32322, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
27. Ley P. Communicating With Patients. 1988;Croom Helm, London.
28. Mehta S., Moore R.D., Graham N.M.H. Potential factors affecting adherence with HIV therapy. AIDS. 11:1997;1665-1670.
29. Miller N.H. Compliance with treatment regimens in chronic asymptomatic diseases. Am. J. Med. 17:1997;43-49.
30. Morin M., Moatti J.P. Observance et essais thérapeutiques: obstacles psychosociaux dans la recherche sur le traitement de l'infection par le VIH. Nature, Sciences et Sociétés. 4:(3):1996;2-15.
31. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 24:1986;67-74.
32. Munzenberger N., Cassuto J.L., Souville M., Morin M., Gastaut J.A., Moatti J.P. L'observance au cours de essais thérapeutiques dans l'infection à VIH: Une discontinuité entre l'histoire des patients et la logique des essais. La Presse médicale. 26:1997;365-365.
33. Myers L.B., Midence K. Adherence to Treatment in Medical Conditions. 1998;Harwood Academic, The Netherlands.
34. Nieuwkerk P.T., Gisolf E.H., Van Leeuwen R., Danner S.A., De Boer J.B., Chesney M.A., Sprangers M.A.G. Self-reported adherence to ritonavir/saquinavir and ritonavir/saquinavir/stavudine in a randomized clinical trial: Preliminary results. Abstract 32362, 12th World AIDS Conference, Geneva, 28 June-3 July. 1998.
35. Ohmit S., Schuman P., Schoenbaum E., Rompalo A., Cohen M., Richardson J., Sacks H., Young M. Adherence to antiretroviral therapy (ART) among women in the HIV Epidemiology Research Study (HERS) and Women's Inter-Agency HIV Study (WIHS). Abstract 32347, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
36. Rosenstock I.M. The health belief model and preventive health behavior. Health Education Monographs. 2:1974;35-86.
37. Samet J.H., Libman H., Steger K.A., Dhawan R., Chen J., Shevitz, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, Type 1: A cross-sectional study in a municipal hospital clinic. Am. J. Med. 92:1992;495-502.
38. Sherr, L., 1998. Adherence and combination therapies, Challenges for social science. AIDS in Europe. New challenges for social and behavioural sciences.
39. Singh N., Squier C., Sivek C., Wagener M., Nguyen M.H., Yu V.L. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 8:(3):1996;261-269.
40. Terry D.J., Gallois G., McCamish. The Theory of Reasoned Action: Its application to AIDS preventive behavior. 1993;Pergamon Press, New York.
41. Tuckett D., Boulton M., Olson C., Williams A. Meetings Between Experts: An approach to sharing ideas in medical consultations. 1986;Tavistock Publ, London.
42. Vincintini R., Fossati A., Bagnato M., Novella L., Brignone S., Pozzoli S., Rossi D., Tambussi G., Maffei C. Compliance to treatment and its relationship with personality disorders in HIV-positive patients. 2nd European Conference on the Methods and Results of Social and Behavioural Sciences: AIDS in Europe. New challenges for social and behavioural sciences. 1998.
43. Warren L., Hixenbaugh P. Adherence and diabetes. Myers L.B., Midence K. Adherence to Treatment in Medical Conditions. 1998;Harwood Academic, The Netherlands.
44. Weidle P.J., Ganea C.E., Ernst J., McGowan J., Irwin K.L., Holberg S.D. Multiple reasons for nonadherence to antiretroviral medications in an inner-city minority population: Need for a multifaceted approach to improve adherence. Abstract 32360, 12th World AIDS Conference Geneva, 28 June-3 July. 1998.
45. Yeni P. Preliminary results of the European/Australian Delta trial. Fifth European Conference on Clinical and Treatment of HIV Infection, Copenhagen. 1995.